Millions of Americans wake up exhausted every day and assume it's simply part of getting older. But chronic fatigue is often a sign that something deeper is going on. In this article, Dr. Bryan Mabry explores the hidden causes of persistent tiredness—from sleep apnea and shift work to stress, hormones, metabolic health, and vitamin deficiencies—and explains why stimulants and supplements often fail to address the root cause.

Medical cannabis continues to face stigma despite growing evidence supporting its therapeutic benefits. This blog explores the double standard between cannabis, alcohol, and tobacco while examining how history, culture, and economics shaped public perception. Discover why the conversation around medical cannabis is shifting toward a more balanced, evidence-based approach focused on patient care and informed choice.

GLP-1 medications may affect more than appetite and weight loss. Many patients report psychological changes such as reduced cravings, altered reward responses, shifts in mood, and changes in emotional eating behaviors. In this article, we explore the potential mental health benefits and risks of GLP-1 medications, helping patients better understand how these treatments may influence both the body and the mind.

A new weight loss pill is here. FOUNDAYO (orforglipron) offers a simpler, needle-free alternative to traditional GLP-1 injections like Semaglutide and Tirzepatide. Find out how it works, how much weight you can expect to lose, and whether this new option is right for you.

Clinical evidence for ibogaine in addiction treatment—primarily from observational studies outside the U.S.—suggests improvements in withdrawal, cravings, and mental health. However, the data is limited by lack of controlled trials, inconsistent protocols, and reliance on self-reported outcomes, raising important questions about reliability, safety, and long-term effectiveness.

You’ve been told your labs are “normal,” but you still feel off—tired, foggy, gaining weight, and not yourself. In 2026, more patients than ever are dealing with hormone imbalance despite normal lab results. This blog breaks down why that happens, including stress, poor sleep, environmental toxins, and metabolic changes—and what you can do about it.

Ibogaine treatment is a non-conventional intervention involving a psychoactive compound from the Tabernanthe iboga plant, producing a 24–72 hour intense physiological and psychological experience. Patients often report profound introspection and emotional insight, but the process carries significant risks, including cardiovascular and psychological concerns. Understanding the full patient experience is essential when evaluating both its therapeutic potential and safety.

Ibogaine is gaining attention as a potential treatment for addiction, particularly opioid dependence, often described as a “reset” for the brain. However, despite growing interest, it remains poorly understood, unapproved in the United States, and primarily used in international settings. Understanding its history, pharmacology, and current applications is essential to evaluating its role in modern addiction treatment.

GLP-1 weight loss treatments like semaglutide and tirzepatide are in high demand—but not all clinics are transparent about pricing. Some bundle medication into service fees, while others mark up drugs behind the scenes. Before starting treatment, it’s critical to understand how these programs are structured so you know exactly what you’re paying for—and what to watch out for.